Cure My Disease

Don't miss your cure!

Log in / Sign up

Dyschromatosis symmetrica hereditaria

MONDO:0007483

Acropigmentation of Dohi is a genodermatosis characterized by the presence of hyperpigmented and hypopigmented macules, principally located on the extremities and limbs.

Also known as: DSH1, RAD, acropigmentation of Dohi, dyschromatosis symmetrica hereditaria, reticulate acropigmentation of Dohi, DSH, dyschromatosis symmetrica hereditaria 1, familial reticulate acropigmentation of Dohi

15 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Hereditary disease (176) Skin disorder (132) Rheumatic disorder (87) Connective tissue disorder (68) Syndromic disease (25) Autoinflammatory syndrome (21) Hyperpigmentation of the skin (15) Human disease (14) Skin pigmentation disorder (11)

Trials to join now! 8 Not yet recruiting 2 Not yet finished but already full! 1 Completed 4

New pill aims to tame rare immune diseases

Disease control Ongoing

This early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…

Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC